Plain-English translation of NCT07521800 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The DRAGON-TAVI trial is testing whether continuous heart monitoring for 30 days after aortic valve replacement surgery helps doctors detect and manage irregular heartbeats more effectively. You'll wear a remote monitoring device that tracks your heart's electrical activity around the clock, and your doctor will schedule visits if anything concerning shows up. This approach is being compared to the standard care most patients receive today: a brief heart tracing in the hospital and one follow-up visit within a month.
Heart rhythm problems are common after valve replacement surgery and can be serious if missed. Doctors want to know whether catching these problems earlier with continuous monitoring—rather than waiting for scheduled visits—leads to better treatment decisions and outcomes for patients.
You likely qualify if…
You likely don't qualify if…
You'll be randomly assigned to either the remote monitoring group or standard care group. If you're in the monitoring group, you'll wear a small device that continuously records your heart's rhythm for 30 days after surgery, and your doctor will contact you for visits whenever the device detects something unusual. You'll have regular follow-up appointments over the next 12 months. Whether in the monitoring or standard care group, you'll be asked to attend visits and allow doctors to check your heart health as part of the study.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Italy
Poland